Seres Therapeutics, Inc. (MCRB) key performance indicators and operating metrics (2 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Relative Risk Reduction in Bloodstream Infections | 77.00 percent | FY2026-Q1 |
| Grant Revenue | 358K | FY2026-Q1 |
Back to MCRB overview · MCRB earnings · MCRB holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.